Ok
Cancel
Don't show this message again
-
Ok CancelDon't show this message again
Compliance with Psychedelics and Emerging Therapies
Debbie Casey, Partner.
Kelly Willenberg, CEO, Kelly Willenberg and Associates.
Linda Iovanni, Director, Clinical Operations.
2023-11-09
-
Discussion of emerging therapies including clinical trials and the future of psychotherapy
-
Discussion of steps that can be taken to mitigate risk and increase protective factors for the subjects
-
Review of integration techniques, resources, legal and ethical issues with these emerging therapies
-